Suppr超能文献

大规模组织干预以提高英国四家医院的患者安全:混合方法评估。

Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluation.

机构信息

School of Health and Population Sciences, University of Birmingham, Edgbaston, West Midlands B15 2TT, UK.

出版信息

BMJ. 2011 Feb 3;342:d195. doi: 10.1136/bmj.d195.

Abstract

OBJECTIVES

To conduct an independent evaluation of the first phase of the Health Foundation's Safer Patients Initiative (SPI), and to identify the net additional effect of SPI and any differences in changes in participating and non-participating NHS hospitals.

DESIGN

Mixed method evaluation involving five substudies, before and after design.

SETTING

NHS hospitals in the United Kingdom.

PARTICIPANTS

Four hospitals (one in each country in the UK) participating in the first phase of the SPI (SPI1); 18 control hospitals.

INTERVENTION

The SPI1 was a compound (multi-component) organisational intervention delivered over 18 months that focused on improving the reliability of specific frontline care processes in designated clinical specialties and promoting organisational and cultural change.

RESULTS

Senior staff members were knowledgeable and enthusiastic about SPI1. There was a small (0.08 points on a 5 point scale) but significant (P < 0.01) effect in favour of the SPI1 hospitals in one of 11 dimensions of the staff questionnaire (organisational climate). Qualitative evidence showed only modest penetration of SPI1 at medical ward level. Although SPI1 was designed to engage staff from the bottom up, it did not usually feel like this to those working on the wards, and questions about legitimacy of some aspects of SPI1 were raised. Of the five components to identify patients at risk of deterioration--monitoring of vital signs (14 items); routine tests (three items); evidence based standards specific to certain diseases (three items); prescribing errors (multiple items from the British National Formulary); and medical history taking (11 items)--there was little net difference between control and SPI1 hospitals, except in relation to quality of monitoring of acute medical patients, which improved on average over time across all hospitals. Recording of respiratory rate increased to a greater degree in SPI1 than in control hospitals; in the second six hours after admission recording increased from 40% (93) to 69% (165) in control hospitals and from 37% (141) to 78% (296) in SPI1 hospitals (odds ratio for "difference in difference" 2.1, 99% confidence interval 1.0 to 4.3; P = 0.008). Use of a formal scoring system for patients with pneumonia also increased over time (from 2% (102) to 23% (111) in control hospitals and from 2% (170) to 9% (189) in SPI1 hospitals), which favoured controls and was not significant (0.3, 0.02 to 3.4; P = 0.173). There were no improvements in the proportion of prescription errors and no effects that could be attributed to SPI1 in non-targeted generic areas (such as enhanced safety culture). On some measures, the lack of effect could be because compliance was already high at baseline (such as use of steroids in over 85% of cases where indicated), but even when there was more room for improvement (such as in quality of medical history taking), there was no significant additional net effect of SPI1. There were no changes over time or between control and SPI1 hospitals in errors or rates of adverse events in patients in medical wards. Mortality increased from 11% (27) to 16% (39) among controls and decreased from 17% (63) to 13% (49) among SPI1 hospitals, but the risk adjusted difference was not significant (0.5, 0.2 to 1.4; P = 0.085). Poor care was a contributing factor in four of the 178 deaths identified by review of case notes. The survey of patients showed no significant differences apart from an increase in perception of cleanliness in favour of SPI1 hospitals.

CONCLUSIONS

The introduction of SPI1 was associated with improvements in one of the types of clinical process studied (monitoring of vital signs) and one measure of staff perceptions of organisational climate. There was no additional effect of SPI1 on other targeted issues nor on other measures of generic organisational strengthening.

摘要

目的

对健康基金会更安全患者倡议(SPI)第一阶段进行独立评估,并确定 SPI 的净附加效果以及参与和不参与 NHS 医院的变化差异。

设计

包含五项子研究的混合方法评估,采用前后设计。

设置

英国 NHS 医院。

参与者

参与 SPI1 的四家医院(英国每个国家各一家);18 家对照医院。

干预措施

SPI1 是一项在 18 个月内实施的复合(多成分)组织干预措施,重点是提高指定临床专业中特定一线护理流程的可靠性,并促进组织和文化变革。

结果

高级工作人员对 SPI1 了解并热情。在员工问卷的 11 个维度之一(组织氛围)中,SPI1 医院有一个小(5 分制 0.08 分)但显著(P < 0.01)的优势。定性证据表明,SPI1 仅在医疗病房层面略有渗透。尽管 SPI1 旨在自下而上地让员工参与,但对于在病房工作的人来说,这感觉并不总是如此,并且对 SPI1 某些方面的合法性提出了质疑。在确定可能恶化的患者的五个组成部分中——监测生命体征(14 项);常规检查(三项);针对特定疾病的循证标准(三项);处方错误(来自英国国家处方集的多项条目);和医疗史记录(11 项)——除了与急性内科患者监测质量有关的方面外,对照组和 SPI1 医院之间几乎没有净差异,所有医院的监测质量都随着时间的推移而有所提高。在 SPI1 医院中,呼吸频率的记录增加到更大的程度;在入院后第二六小时,对照组的记录从 40%(93 人)增加到 69%(165 人),SPI1 医院从 37%(141 人)增加到 78%(296 人)(差异比 2.1,99%置信区间 1.0 至 4.3;P = 0.008)。用于肺炎患者的正式评分系统的使用也随着时间的推移而增加(对照组从 2%(102 人)增加到 23%(111 人),SPI1 医院从 2%(170 人)增加到 9%(189 人)),这有利于对照组,但不显著(0.3,0.02 至 3.4;P = 0.173)。处方错误的比例没有改善,也没有可以归因于 SPI1 的非靶向通用领域的效果。在某些措施上,缺乏效果可能是因为在基线时已经遵守率很高(例如,在需要的情况下,超过 85%的情况下使用类固醇),但即使在有更多改进空间的情况下(例如在医疗史记录质量方面),SPI1 也没有显著的额外净效果。在医疗病房的患者中,没有观察到错误或不良事件发生率随时间或对照和 SPI1 医院的变化。对照组的死亡率从 11%(27 人)增加到 16%(39 人),SPI1 医院的死亡率从 17%(63 人)下降到 13%(49 人),但风险调整差异无统计学意义(0.5,0.2 至 1.4;P = 0.085)。在通过病历审查确定的 178 例死亡病例中,护理不佳是四个死亡病例的一个促成因素。患者调查显示,除了 SPI1 医院的清洁度感知增加外,没有其他显著差异。

结论

SPI1 的引入与研究的一种临床流程类型(生命体征监测)和一种员工对组织氛围感知的衡量标准的改进有关。SPI1 对其他目标问题或其他通用组织强化措施没有额外效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验